The United States represents the largest contributor to the Bioconjugation Market, supported by a highly developed biotechnology ecosystem, advanced pharmaceutical research infrastructure, and substantial healthcare investments. The country is home to numerous biopharmaceutical companies, academic research institutions, and contract research organizations that actively utilize bioconjugation...